Lyra Therapeutics Inc

0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)45.65M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$1.13 Million
Adjusted EPS-$0.79
See more estimates
10-Day MA$3.80
50-Day MA$4.65
200-Day MA$7.16
See more pivots

Lyra Therapeutics Inc Stock, NASDAQ:LYRA

480 Arsenal Way, Watertown, Massachusetts 02472
United States of America
Phone: +1.617.393.4600
Number of Employees: 38


Lyra Therapeutics, Inc. is a clinical-stage therapeutics company. It develops novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat, or ENT, diseases. The firms proprietary XTreo deliver medicines. The company was founded by Carmichael S. Roberts, George M. Whitesides, and Robert S. Langer in November 2005 and is headquartered in Watertown, MA.